Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Emre Yucel on LinkedIn: How is it possible that such dangerous copycat eyedrops made way to the…

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma - ScienceDirect

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. - Abstract - Europe PMC

Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma – The Oregon Health and Science University Experience - ScienceDirect

JPatientRepOutcomes (@JPRO_ISOQOL) / X

Treatment With KRd Plus Autologous Stem Cell Transplant Elicits Durable Survival Benefit in Myeloma

Cancers, Free Full-Text

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

View of Ciltacabtagene Autoleucel (Carvykti)

Kaplan-Meier Curves for Progression-free Survival and Overall Survival

OUH - Group members

Multiple myeloma - ScienceDirect

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma, Experimental Hematology & Oncology

Sören Möller — University of Southern Denmark